Aspirin or dipyridamole use reduces risk of retinopathy in diabetics: study Dr. Shravani Dali24 April 2022 9:00 PM ISTPatients with type 2 diabetes benefit from aspirin or dipyridamole therapy in terms of a reduced risk of developing non-proliferative diabetic...
No reduction in stroke, mini strokes, blood clotting in the brain or changes in cognitive function with edoxaban after TAVR Dr. Kamal Kant Kohli14 April 2022 9:00 AM ISTPatients treated with the blood thinner edoxaban for six months after a heart valve replacement procedure experienced fewer symptomless blood clots...
Cilostazol effective drug in preventing stroke in men than women Dr. Nandita Mohan26 March 2022 5:30 PM ISTDual antiplatelet therapy (DAPT) is highly effective in preventing atherothrombotic complications in patients with previous myocardial infarction and...
Dual antiplatelet therapy effective: MASTER DAPT Trial Dr. Nandita Mohan9 Feb 2022 6:45 PM ISTFatal heart diseases are most commonly caused by formation of clots in major blood vessels, its a serious risk that needs to be managed...
Study Finds New Evidence on Personalized Selection of Antiplatelet Therapy MD Bureau3 Feb 2022 9:00 AM ISTOral P2Y12 inhibitors (clopidogrel, prasugrel, and ticagrelor) used in conjunction with aspirin constitute a key strategy for the prevention of...
Antiplatelet therapy-induced GI injury occurs even in patients at low bleeding risk: JACC Medha Baranwal29 Dec 2021 9:00 AM ISTChina: Results from a double-blind, randomized OPT-PEACE trial showed that almost all patients (at low bleeding risk) who received antiplatelet...
Dual antiplatelet therapy equally effective in acute coronary syndrome Dr. Nandita Mohan10 Nov 2021 5:42 PM ISTThe appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent...
One month DAPT non-inferior to standard regimens in high bleeding risk patients: MASTER DAPT trial dr. Abhimanyu Uppal6 Nov 2021 11:15 AM ISTThe appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent...
Clopidogrel superior to aspirin in reducing adverse events after PCI with DES: Lancet Medha Baranwal9 July 2021 10:45 AM ISTClopidogrel monotherapy reduced long-term rates of all-cause mortality, non-fatal myocardial infarction, and stroke after drug-eluting stent placement...
Crushed Prasugrel significantly Lowers Platelet Activity In Patients undergoing PCI: Study MD Bureau6 July 2021 10:30 AM ISTWhen crushed Prasugrel is administered to patients with suspected STEMI, it significantly lowered the platelet activity.
Study reinforces benefits of long-term duel antiplatelet therapy for ACS patients Hina Zahid29 April 2021 6:15 AM ISTWASHINGTON, D.C - An analysis of the prospective Fuwai PCI Registry, confirms long-term dual antiplatelet therapy (DAPT) is an optimal treatment...
Prior antiplatelet therapy tied to adverse outcomes in intracerebral hemorrhage: Study Medha Baranwal12 March 2021 8:49 PM ISTUK: Prior antiplatelet therapy in intracerebral hemorrhage (ICH) patients increases risk of hematoma expansion and leads to less favorable outcomes...
